Kings College Hospital; Neurosciences Clinical Trials Office

London SE5 9NT

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed